MedXpress – Glucagon, GLP-1 co-infusion can reduce appetite

Co-infusion of glucagon and glucagon-like peptide 1 (GLP-1) correlates with a reduction in appetite, and GLP-1 protects against glucagon-induced hyperglycemia in healthy volunteers, according to a study published online June 17 in Diabetes.

Read more

Posted in Glucose & Insulin